941
Views
12
CrossRef citations to date
0
Altmetric
Research Paper

Circ-FOXM1 knockdown suppresses non-small cell lung cancer development by regulating the miR-149-5p/ATG5 axis

, , , , , & show all
Pages 166-178 | Received 14 Apr 2020, Accepted 16 Dec 2020, Published online: 08 Jan 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Wei Li, Pan Yang, Chucheng Zhong, Xiaozhen Shen, Xingyuan Shi & Xiaoping Li. (2022) The circ-PITX1 promotes non-small cell lung cancer development via the miR-30e-5p/ITGA6 axis. Cell Cycle 21:3, pages 304-321.
Read now

Articles from other publishers (11)

Xiaofang Zhu, Jing Wan, Xu You, Wanli Yang & Lei Zhao. (2023) Circular non‐coding RNA circ_0072088 serves as a ceRNA , targeting the miR ‐1225‐5p/ WT1 axis to regulate non‐small cell lung cancer cell malignant behavior . Thoracic Cancer 14:20, pages 1969-1979.
Crossref
YanFei Wang, JieMing He, YongXue Liang & DaLin Xiong. (2023) Hsa_circ_0102899 promotes epithelial–mesenchymal transition in non-small cell lung cancer. Clinical and Translational Oncology.
Crossref
Pengli Zhou, Zhou Zhang, Mingyue Liu, Ping Li & Ying Zhu. (2023) Effects of autophagy‑related gene 5 on tumor development and treatment (Review). Oncology Reports 50:2.
Crossref
Mustafa M. Kadhim, Andrés Alexis Ramírez-Coronel, Abduladheem Turki Jalil, Hayder Abdullah Talib, Jitendra Gupta, Zanko Hassan Jawhar, Marwan Mahmood Saleh, Vijay Pandey, Xi Zhang & Haroon Khan. (2023) Autophagy as a self-digestion signal in human cancers: Regulation by microRNAs in affecting carcinogenesis and therapy response. Pharmacological Research 189, pages 106695.
Crossref
Yiyang Sun, Ping He, Li Li & Xue Ding. (2023) The significance of the crosstalk between ubiquitination or deubiquitination and ncRNAs in non-small cell lung cancer. Frontiers in Oncology 12.
Crossref
Bashdar Mahmud Hussen, Snur Rasool Abdullah, Goran Sedeeq Hama Faraj, Mohammed Fatih Rasul, Abbas Salihi, Soudeh Ghafouri-Fard, Mohammad Taheri & Majid Mokhtari. (2022) Exosomal circular RNA: a signature for lung cancer progression. Cancer Cell International 22:1.
Crossref
Yang Shen, Nan Zhao, Nan Zhao, Xinyao Hu, Xiaoqin He, Yangtao Xu, Jiayu Chen, Wenliang Chen, Xin Liu, Zhuolin Zhou, Dedong Cao & Ximing Xu. (2022) Tumor-Suppressive and Oncogenic Roles of microRNA-149-5p in Human Cancers. International Journal of Molecular Sciences 23:18, pages 10823.
Crossref
Ying Liu, Xiang Ao, Wanpeng Yu, Yuan Zhang & Jianxun Wang. (2022) Biogenesis, functions, and clinical implications of circular RNAs in non-small cell lung cancer. Molecular Therapy - Nucleic Acids 27, pages 50-72.
Crossref
Lei Wang, Cimei Zeng, Zhongren Chen, Jianxu Qi, Sini Huang, Haimei Liang, Shiren Huang & Zongxing Ou. (2022) Circ_0025039 acts an oncogenic role in the progression of non-small cell lung cancer through miR-636-dependent regulation of CORO1C. Molecular and Cellular Biochemistry 477:3, pages 743-757.
Crossref
Jianqiang Liang, Lin Zhang & Wenjun Cheng. (2021) Non-coding RNA-mediated autophagy in cancer: A protumor or antitumor factor?. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1876:2, pages 188642.
Crossref
Fu-jia Ren, Yao Yao, Xiao-yu Cai, Yu-ting Cai, Qian Su & Guo-ying Fang. (2021) MiR-149-5p: An Important miRNA Regulated by Competing Endogenous RNAs in Diverse Human Cancers. Frontiers in Oncology 11.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.